|
|
|
|
 |
|
| Welcome to the Clinical Testing Solutions newsletter, March 2022. In this edition you'll find details on a webinar about responding to SARS‑CoV‑2 variants, including Omicron. Read blog posts on COVID‑19 testing solutions exploring variant detection and the rise of “Flurona”. Learn how Thermo Fisher Scientific is preparing for the IVDR transition ahead of the regulation taking effect in May 2022. Discover valuable information on HIV genotyping surveillance, clinical conversations on limiting risks of antimicrobial resistance in the diagnosis of UTIs, and the advantages of using pharmacogenomics in patient care. The 32nd ECCMID takes place in Lisbon this year—join us there on 23–26 April. |
|
|
|
|
|
|
|
Webinar: Responding to SARS‑CoV‑2 variants, such as Omicron
Join this exciting webinar to learn more about detecting variants of concern, including Omicron. Explore how molecular diagnostic solutions help with variant surveillance and the fight against COVID‑19.
Register now »
|
|
|
|
|
 |
Can you tell which COVID-19 variant you have?
Probably not. But someone processing your COVID-19 test in a lab might be able to guess. Learn more in this CNET article, featuring Thermo Fisher Scientific's Dr. Manoj Gandhi.
Read article » |
|
 |
Let's talk about Flurona
“Flurona” is making headlines as new COVID‑19 cases continue to rise. But what exactly is it and how concerned should we be?
Read blog » |
|
|
| Prepare for the IVDR transition |
|
The new European Union legislation for in vitro diagnostic medical devices, In Vitro Diagnostic Regulation (IVDR), will be applied on 26 May 2022. Discover how Thermo Fisher Scientific is committed to supporting clinical laboratories across the EU in preparation for the transition to this new regulation.
|
|
|
| HIV genotyping surveillance |
|
 |
Epidemiologic and genetic surveillance
The emerging challenge of antiretroviral therapy (ART) resistance and the importance of surveillance in the fight against HIV.
Read blog » |
|
 |
Monitoring for integrase inhibitor resistance
To prevent further development of drug resistance, the WHO recommends surveillance programmes include integrase region analysis.
Read blog » |
|
|
 |
On-demand webinar: HIV‑1 genotyping targeting integrase
Learn about the state of HIV-1 genotyping in public health surveillance research and the results from local efforts in South Africa to monitor the state of HIV evolution.
Watch now » |
|
|
|
|
Urinary tract infections: an opportunity for antimicrobial stewardship
Dr. Ari Frenkel discusses the ways in which healthcare providers diagnose and treat UTIs can have a profound effect on limiting risks of antimicrobial resistance, direct patient care and their subsequent outcomes, and the costs to the healthcare system.
Read blog »
|
|
|
|
Pharmacogenomics brings advantages to patient care
Despite its challenges, pharmacogenomics (PGx) has the potential to play a critical role in patient care. Learn how Precision Genetics successfully brought clinical PGx into practice and what changes are needed to make PGx standard of care.
Read blog »
|
|
|
|
|
|
|
Connect
